Search Results 851-860 of 16313 for Chronic Lymphocytic Leukemia

1. Unexplained weight loss When to see a doctor - Mayo Clinic

   Chemotherapy side effects: A cause of heart disease? Chronic lymphocytic leukemia · Chronic myelogenous leukemia · Churg-Strauss syndrome · Cirrhosis · What is ...

2. Monoclonal antibody drugs for cancer: How they work - Mayo Clinic

   Serious, but rare, side effects of monoclonal antibody therapy may include: Infusion reactions. Severe allergy-like reactions can occur and, very rarely, lead ...

3. Study of TJ011133 in Participants With Relapsed/ Refractory Advanced Solid Tumors and Lymphoma - Mayo Clinic

   Subjects with Burkitt's lymphoma, lymphoblastic lymphoma, Richter's transformation, primary effusion lymphoma or chronic lymphocytic leukemia/small lymphocytic ...

4. Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy - Mayo Clinic News Network

   This therapy resulted in overall response rates of up to 90% in B-cell acute lymphoblastic leukemia and 50%–80% in lymphoma. ... long-term product pipeline.

5. Acute myelogenous leukemia - Doctors and departments - Mayo Clinic

   Mayo Clinic doctors and researchers are studying the latest in diagnosis and treatment of acute myelogenous leukemia. The Hematologic Malignancies Program ...

6. Acute myelogenous leukemia - Doctors and departments - Mayo Clinic

   Mayo Clinic doctors and researchers are studying the latest in diagnosis and treatment of acute myelogenous leukemia. The Hematologic Malignancies Program ...

7. Acute myelogenous leukemia - Doctors and departments - Mayo Clinic

   Mayo Clinic doctors and researchers are studying the latest in diagnosis and treatment of acute myelogenous leukemia. The Hematologic Malignancies Program ...

8. Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Relapsed/Refractory Large B-cell Lymphoma - Mayo Clinic

   History of Richter's transformation of chronic lymphocytic leukemia (CLL). Prior CAR therapy or other genetically modified T-cell therapy. History of severe ...

9. SGI-110 in Patients with Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) - Mayo Clinic

   ... Chronic Myelomonocytic Leukemia (CMML) or AML. In the Dose Escalation Segment, patients who are refractory, relapsed, or unresponsive to standard treatment ...

10. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

    Phase 4 trials look at long-term safety and ... leukemia patients when given by intravenous infusion at various doses. ... Bone lesions: lytic lesions, severe ...